BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30711300)

  • 1. Disparities in gynecologic cancer genetics evaluation.
    Hinchcliff EM; Bednar EM; Lu KH; Rauh-Hain JA
    Gynecol Oncol; 2019 Apr; 153(1):184-191. PubMed ID: 30711300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Chen LM; Richardson DL;
    Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of testing for germline
    Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
    Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
    Ring KL; Modesitt SC
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):155-173. PubMed ID: 29428283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future role of genetic screening in gynecologic malignancies.
    Ring KL; Garcia C; Thomas MH; Modesitt SC
    Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
    Griffin NE; Buchanan TR; Smith SH; Leon AA; Meyer MF; Liu J; Tabak RG; Fuh KC; Thaker PH; Powell MA; Mutch DG; Massad LS; Colditz GA; Hagemann AR
    Gynecol Oncol; 2020 Jan; 156(1):140-146. PubMed ID: 31780235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and Somatic Tumor Testing in Gynecologic Cancer Care.
    Alldredge J; Randall L
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):37-53. PubMed ID: 30683265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.
    Tindale LC; Zhantuyakova A; Lam S; Woo M; Kwon JS; Hanley GE; Knoppers B; Schrader KA; Peacock SJ; Talhouk A; Dummer T; Metcalfe K; Pashayan N; Foulkes WD; Manchanda R; Huntsman D; Stuart G; Simard J; Dawson L
    Curr Oncol; 2022 Jun; 29(7):4632-4646. PubMed ID: 35877228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
    Mitchell G; Schrader KA
    Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of genetic syndromes predisposing to gynecologic cancers.
    Miesfeldt S; Lamb A; Duarte C
    Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in genetic testing: thinking outside the BRCA box.
    Hall MJ; Olopade OI
    J Clin Oncol; 2006 May; 24(14):2197-203. PubMed ID: 16682739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic prediction of risk for gynecologic cancers.
    Randall LM; Pothuri B
    Gynecol Oncol; 2016 Apr; 141(1):10-6. PubMed ID: 27016223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
    Hall MJ; Obeid EI; Schwartz SC; Mantia-Smaldone G; Forman AD; Daly MB
    Gynecol Oncol; 2016 Mar; 140(3):565-74. PubMed ID: 26812021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection and risk reduction for familial gynecologic cancers.
    Chen LM; Karlan BY
    Clin Obstet Gynecol; 1998 Mar; 41(1):200-14. PubMed ID: 9504236
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary gynecologic tumors and precision cancer medicine.
    Ogawa C; Hirasawa A; Ida N; Nakamura K; Masuyama H
    J Obstet Gynaecol Res; 2022 May; 48(5):1076-1090. PubMed ID: 35229413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.